Tilray Brands Acquires Lyphe Group in Europe | Cannabis Equipment News
Corporate consolidation European medical cannabis markets directly affects patient access and product availability. Clinicians should monitor these changes to anticipate impacts on prescribing cannabis-based medicines. Understanding market dynamics helps…
Pennsylvania House Passes Budget Plan Including Cannabis Revenue Projections
The Pennsylvania cannabis budget plan includes projected marijuana revenue despite legalization not yet in place. This budget plan signals strong legislative confidence in future cannabis legalization. Clinicians should prepare for changes affecting…
Cannabis Sales Plummet as Regulators Crack Down on Booming Industry
Cannabis market disruption is intensifying as regulators crack down on the booming industry. This enforcement affects patient access to therapeutic cannabis and treatment continuity. Clinicians must understand these changes to support patient care…
Boston’s First Recreational Cannabis Shop Closes After Six Years
Cannabis retail market consolidation is disrupting patient access to consistent products, especially for medical cannabis users. The closure of Boston's first recreational cannabis shop highlights these challenges. Patients face supply chain disruptions…
Aurora Cannabis Acquires Safari Flower Company for C$26.5M
Corporate mergers cannabis activity continues to reshape the medical cannabis landscape. Aurora Cannabis's acquisition of Safari Flower Company for C$26.5M highlights this trend. This merger may affect product availability and quality control for…
Tennessee Lawmakers Aim to Take Cannabis Rescheduling Out of Expert Hands
Tennessee cannabis rescheduling legislation proposes shifting authority from medical experts to lawmakers. This change threatens clinical autonomy and patient access to cannabis therapeutics. Understanding this legislation is crucial for healthcare…
Millions of Texans Gain Access to Medical Cannabis
Texas medical cannabis expansion has made millions of Texans eligible for treatment under new qualifying conditions. This policy change broadens patient access while maintaining regulated oversight. Healthcare providers should stay informed about these…
Tilray Acquires UK Medical Cannabis Firm, Files $180M Equity Program
Industry consolidation medical cannabis is reshaping patient access and product availability. Tilray's acquisition of a UK firm and $180M equity program highlight this trend. These developments may influence regulatory pathways and clinical research…
Understanding Pending Medical Cannabis and Hemp Legislation in Georgia
The Georgia medical cannabis legislation update highlights important changes affecting patient access and clinical practice. Pending laws may expand qualifying conditions and THC limits. Clinicians and patients should stay informed about these evolving…
Self-reported reasons for medical and nonmedical cannabis use in Australia: A cross-sectional analysis of the International Cannabis Policy Study 2023.
This study highlights dual-use cannabis consumption among Australian adults, showing that many combine medical and nonmedical cannabis. Dual-use cannabis consumption represents a significant portion of users, reflecting real-world use beyond regulatory…